Kazuyuki Komori

Kazuyuki Komori

Auto-generated profile, based on publicly available information

Kazuyuki Komori

Departmant of Thoracic Surgery, National Defense Medical College, Tokorozawa, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2018 in General Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
KKKazuyuki Komori
Kazuyuki Komori
AHAritoshi Hattori
Aritoshi Hattori
TMTakeshi Matsunaga
Takeshi Matsunaga
KTKazuya Takamochi
Kazuya Takamochi
SOShiaki Oh
Shiaki Oh
KSKenji Suzuki
Kenji Suzuki

2 April 2022 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
HHHiroshi Hashimoto
Hiroshi Hashimoto
KKKazuyuki Komori
Kazuyuki Komori
KKKoji Kameda
Koji Kameda
STShinichi Taguchi
Shinichi Taguchi
YOYuichi Ozeki
Yuichi Ozeki
Background: Anaplastic lymphoma kinase (ALK)–tyrosine kinase inhibitors (TKIs) have been approved for the therapy of locally advanced non-small cell lung cancer (NSCLC) caused by ALK rearrangement. However, its treatment after failure of initial ALK–TKI therapy remains controversial. Case presentation: A 47-year-old woman with a hemosputum was diagnosed with adenocarcinoma of the left lung (cT2bN3M0, stage IIIB). Gene mutation analysis indicated positive ALK translocation. Alectinib was selected as the first-line treatment. Although the treatment effect was determined as a partial response, the main tumor regrew. Alectinib was discontinued, and salvage surgery was performed without causing morbidity. The pathological diagnosis was pleomorphic carcinoma without lymph node metastasis (yp-T2bN0). After surgery, lorlatinib was administered as the second-line treatment for 8 months until the patient could not tolerate continuation. Computed tomography scan revealed no lung cancer recurrence 14 months after discontinuation. Conclusions: Our experience with this case suggests that salvage surgery after alectinib treatment followed by lorlatinib therapy may be effective for initially unresectable ALK-positive NSCLC.

27 April 2022 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
KKKazuyuki Komori
Kazuyuki Komori
HHHiroshi Hashimoto
Hiroshi Hashimoto
KYKotaro Yoshikawa
Kotaro Yoshikawa
KKKoji Kameda
Koji Kameda
STShinichi Taguchi
Shinichi Taguchi
YOYuichi Ozeki
Yuichi Ozeki
Background: A mediastinal mediobasal segmental pulmonary artery (A7) from the right main pulmonary artery is extremely rare. Case presentation: We report the case of a 71-year-old woman with an aberrant mediastinal A7 who underwent right lower lobectomy for lung cancer (cT1bN0M0, stage IA2). Preoperative three-dimensional computed tomography (CT) angiography revealed an aberrant mediastinal A7 in the right main pulmonary artery. Right lower lobectomy and mediastinal lymph node dissection were performed. Intraoperatively, A7 was observed between the superior and inferior pulmonary veins and in the front of the lower bronchus near the anterior hilum. The artery was carefully dissected from the caudal side after inferior pulmonary vein dissection. The lung parenchyma, which was within the fissure due to poor lobulation between the middle and lower lobes, was safely divided. Conclusions: Thoracic surgeons need to carefully evaluate CT angiography or enhanced multidetector CT findings at preoperative conferences and always keep this anomaly in mind.

23 September 2021 in Research Square
Verified
Preprint
Open access
PDF file
KKKazuyuki Komori
Kazuyuki Komori
HHHiroshi Hashimoto
Hiroshi Hashimoto
KYKotaro Yoshikawa
Kotaro Yoshikawa
KKKoji Kameda
Koji Kameda
STShinichi Taguchi
Shinichi Taguchi
YOYuichi Ozeki
Yuichi Ozeki
Background A mediastinal mediobasal segmental pulmonary artery (A7) from the right main pulmonary artery is extremely rare. Case presentation: We have reported a case of a 71-year-old woman with aberrant A7 who underwent right lower lobectomy for lung cancer (cT1bN0M0, stage IA2). Preoperative three-dimensional computed tomography (CT) angiography revealed an aberrant mediastinal A7 from the right main pulmonary artery. Right lower lobectomy and mediastinal lymph node dissection were performed. Intraoperatively, A7 was observed between the superior and inferior pulmonary veins, and at the front of the lower bronchus near the anterior hilum. The artery was carefully dissected from the caudal side after dissection of the inferior pulmonary vein. Then, the lung parenchyma, which was within the fissure due to poor lobulation between the middle and lower lobes, was safely divided. Conclusions Thoracic surgeons need to evaluate CT angiography or enhanced multidetector CT carefully at preoperative conferences and always keep this anomaly in mind.

1 January 2021 in International Journal of Case Reports and Images
Verified
Journal Article
Open access
KKKazuyuki Komori
Kazuyuki Komori
HHHiroshi Hashimoto
Hiroshi Hashimoto
KYKotaro Yoshikawa
Kotaro Yoshikawa
KKKoji Kameda
Koji Kameda
STShinichi Taguchi
Shinichi Taguchi
YOYuichi Ozeki
Yuichi Ozeki